Hudson Therapeutics, U.S. Subsidiary of Shaperon, Starts NuGel
10 Mar 2025 //
BUSINESSWIRE
Hudson Therapeutics And Shaperon Pursue Global Licensing Partners
07 Oct 2024 //
BUSINESSWIRE
Hudson Therapeutics Enters Alopecia Areata Market
26 Sep 2024 //
BUSINESSWIRE